Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

Goktas Aydin S., Kutlu Y., Muglu H., Aydin A., Acikgoz Ö., Hamdard J., ...Daha Fazla

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.93, ss.71-78, 2024 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 93
  • Basım Tarihi: 2024
  • Doi Numarası: 10.1007/s00280-023-04592-x
  • Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CINAHL, EMBASE
  • Sayfa Sayıları: ss.71-78
  • Anahtar Kelimeler: mGPS, Castration-resistant prostate cancer, Abiraterone, Enzalutamide, Objective response rate, PSA doubling time
  • İstanbul Medipol Üniversitesi Adresli: Evet